ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 71 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,908 | -41.5% | 27,541 | -33.7% | 0.00% | – |
| Q2 2023 | $95,498 | -25.4% | 41,521 | -1.7% | 0.00% | – |
| Q1 2023 | $127,987 | +19.0% | 42,240 | -8.5% | 0.00% | – |
| Q4 2022 | $107,562 | +32.8% | 46,164 | +8.3% | 0.00% | – |
| Q3 2022 | $81,000 | -35.2% | 42,626 | -7.7% | 0.00% | – |
| Q2 2022 | $125,000 | +8.7% | 46,180 | +19.3% | 0.00% | – |
| Q1 2022 | $115,000 | -32.4% | 38,705 | -11.2% | 0.00% | – |
| Q4 2021 | $170,000 | -6.1% | 43,591 | +3.4% | 0.00% | – |
| Q3 2021 | $181,000 | -44.8% | 42,163 | -61.0% | 0.00% | – |
| Q2 2021 | $328,000 | +67.3% | 108,093 | +97.6% | 0.00% | – |
| Q1 2019 | $196,000 | -16.9% | 54,700 | -11.2% | 0.00% | -100.0% |
| Q4 2018 | $236,000 | -54.1% | 61,624 | +13.3% | 0.00% | 0.0% |
| Q3 2018 | $514,000 | +30.5% | 54,394 | +0.7% | 0.00% | 0.0% |
| Q2 2018 | $394,000 | – | 54,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COWEN AND COMPANY, LLC | 4,331,020 | $7,882,000 | 1.31% |
| RTW INVESTMENTS, LP | 6,869,281 | $12,502,000 | 0.35% |
| A.R.T. Advisors, LLC | 14,140 | $26,000 | 0.04% |
| Hudson Bay Capital Management LP | 975,000 | $1,774,000 | 0.03% |
| Secure Asset Management, LLC | 10,000 | $18,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,774,935 | $3,230,000 | 0.01% |
| FNY Investment Advisers, LLC | 9,900 | $18,000 | 0.01% |
| Squarepoint Ops LLC | 322,225 | $586,000 | 0.01% |
| LMR Partners LLP | 107,912 | $196,000 | 0.01% |
| Virtu Financial LLC | 17,147 | $31,000 | 0.00% |